- Home
- MEI vs RCKT Comparison
MEI vs RCKT Comparison
Compare MEI & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MEI
- RCKT
- Stock Information
- Founded
- MEI 1946
- RCKT 1999
- Country
- MEI United States
- RCKT United States
- Employees
- MEI N/A
- RCKT N/A
- Industry
- MEI Electrical Products
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- MEI Technology
- RCKT Health Care
- Exchange
- MEI Nasdaq
- RCKT Nasdaq
- Market Cap
- MEI 231.0M
- RCKT 328.6M
- IPO Year
- MEI N/A
- RCKT N/A
- Fundamental
- Price
- MEI $7.66
- RCKT $3.28
- Analyst Decision
- MEI Buy
- RCKT Buy
- Analyst Count
- MEI 2
- RCKT 13
- Target Price
- MEI $10.50
- RCKT $12.96
- AVG Volume (30 Days)
- MEI 404.9K
- RCKT 6.0M
- Earning Date
- MEI 09-03-2025
- RCKT 08-07-2025
- Dividend Yield
- MEI 3.62%
- RCKT N/A
- EPS Growth
- MEI N/A
- RCKT N/A
- EPS
- MEI N/A
- RCKT N/A
- Revenue
- MEI $1,048,100,000.00
- RCKT N/A
- Revenue This Year
- MEI N/A
- RCKT N/A
- Revenue Next Year
- MEI $0.44
- RCKT $108.43
- P/E Ratio
- MEI N/A
- RCKT N/A
- Revenue Growth
- MEI N/A
- RCKT N/A
- 52 Week Low
- MEI $5.08
- RCKT $2.19
- 52 Week High
- MEI $17.45
- RCKT $22.01
- Technical
- Relative Strength Index (RSI)
- MEI 63.37
- RCKT 51.17
- Support Level
- MEI $6.52
- RCKT $2.88
- Resistance Level
- MEI $7.83
- RCKT $3.74
- Average True Range (ATR)
- MEI 0.28
- RCKT 0.27
- MACD
- MEI 0.18
- RCKT 0.02
- Stochastic Oscillator
- MEI 90.14
- RCKT 35.43
About MEI Methode Electronics Inc.
Methode Electronics Inc supplier of custom-engineered solutions with sales, engineering, and manufacturing locations in North America, Europe, the Middle East, and Asia. It designs, engineers, and produces mechatronic products for Original Equipment Manufacturers (OEMs) utilizing a broad range of technologies for user interface, light-emitting diode (LED) lighting systems, power distribution, and sensor applications. The firm is organized into various business segments: Automotive, Industrial, Interface, and Medical. The Automotive segment, which generates maximum revenue, supplies electronic and electro-mechanical devices and related products to automobiles, including overhead and center consoles, hidden and ergonomic switches, insert molded components, LED-based lighting, and sensors.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.